Skip to main content

Advertisement

SpringerLink
Log in

MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Angiogenesis is a critical biological process essential for solid cancer growth and metastasis. It has been shown that microRNAs (miRNAs) play a vital role in a variety of biological processes in cancers. However, whether miR-130b is involved in prostate cancer angiogenesis remains ill-defined.

Methods

We performed the miRNA microarray to analyze miRNA expression in human prostate cancer specimens. In vitro gain-of-function assays and loss-of-function assays were conducted to explore the potential functions of miR-130b in human prostate cancer cells. Correlation analysis and dual-luciferase reporter assay were performed to validate whether tumor necrosis factor-α (TNF-α) was a direct target of miR-130b. The Matrigel plug and tumor vascular imaging assays were performed to confirm the anti-angiogenic activity of miR-130b in nude mice.

Results

We found that miR-130b was one of the miRNAs being most significantly downregulated. Subsequently, we found that miR-130b expression was markedly downregulated in human prostate cancer cell lines. Down-regulation of miR-130b in prostate cancer cells significantly promoted the proliferation, invasion and tubule formation of human umbilical vein endothelial cells (HUVECs), while ectopic expression of miR-130b blocked prostate cancer angiogenesis in vitro and in vivo. Mechanistic analyses indicated that tumor necrosis factor-α (TNF-α) was regulated by miR-130b directly. MiR-130b attenuated nuclear factor-κB (NF-κB) signaling and its downstream gene vascular endothelial growth factor-A (VEGFA) by directly inhibiting TNF-α expression. Additionally, subsequent investigations identified that the ectopic level of VEGFA markedly abrogated the anti-angiogenic effect induced by miR-130b. Interestingly, VEGFA could in turn decrease the expression of miR-130b, thus forming a negative feedback loop that drives the angiogenesis of prostate cancer.

Conclusion

These findings show that miR-130b/TNF-α/NF-κB/VEGFA feedback loop is significantly correlated with angiogenesis in prostate cancer and miR-130b could be regarded as potential therapeutic target for prostate cancer anti-angiogenesis treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

miRNAs:

MicroRNAs

TNF-α:

Tumor necrosis factor-α

NF-κB:

Nuclear factor-κB

HUVECs:

Human umbilical vein endothelial cells

UTRs:

Untranslated regions

CM:

Conditioned medium

CCK-8:

Cell counting kit-8

RT-PCR:

Reverse transcription polymerase chain reaction

wt:

Wild type

mut:

Mutant

EMSA:

Electrophoretic mobility shift assay

VCAM-1:

Vascular cell adhesion molecule-1

ICAM-1:

Intracellular adhesion molecule-1

References

  1. Scher HI, Solo K, Valant J, et al. Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model. PLoS One. 2015;10(10):e0139440.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Owens OL, Jackson DD, Thomas TL, et al. Prostate cancer knowledge and decision making among African-American men and women in the Southeastern United States. Int J Men’s Health. 2015;14(1):55–70.

    Google Scholar 

  3. Pellegrini KL, Sanda MG, Patil D, et al. Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality. BJUI. 2017;119(6):961–7.

    Article  CAS  Google Scholar 

  4. Rycaj K, Li H, Zhou J, et al. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Semin Cancer Biol. 2017;44:83–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ci X, Xing C, Zhang B, et al. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation. Mol Cancer. 2015;14:91.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Walter BA, Valera VA, Pinto PA, et al. Comprehensive microRNA profiling of prostate cancer. J Cancer. 2013;4(5):350–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Khanmi K, Ignacimuthu S, Paulraj MG, et al. MicroRNA in prostate cancer. Clin Chim Acta. 2015;451:154–60.

    Article  CAS  PubMed  Google Scholar 

  8. Li Q, Lu S, Li X, et al. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. Clin Transl Oncol. 2017;19(5):562–70.

    Article  CAS  PubMed  Google Scholar 

  9. Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982–10982.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Liu A, Hou C, Chen H, et al. Genetics and epigenetics of glioblastoma: applications and overall incidence of IDH1 mutation. Front Oncol. 2016;6:16.

    PubMed  PubMed Central  Google Scholar 

  11. Ali Hosseini Rad SM, Bavarsad MS, Arefian E, et al. The role of microRNAs in stemness of cancer stem cells. Oncol Rev. 2013;7(1):e8.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shahjahani M, Khodadi E, Seghatoleslami M, et al. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy. Oncol Rev. 2015;9(1):261.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Dong P, Karaayvaz M, Jia N, et al. Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2013;32(27):3286–95.

    Article  CAS  PubMed  Google Scholar 

  14. Yip L, Kelly L, Shuai Y, et al. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol. 2011;18(7):2035–41.

    Article  PubMed  Google Scholar 

  15. Zhao G, Zhang JG, Shi Y, et al. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One. 2013;8(9):e73803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhao Yanyang, Miao Gang, Li Yao, et al. MicroRNA-130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1. PLoS One. 2014;9(2):e87938.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Duan J, Zhang H, Qu Y, et al. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer. Oncotarget. 2016;7(28):44522–33.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Li S, Geng J, Xu X, et al. miR-130b-3p modulates epithelial–mesenchymal crosstalk in lung fibrosis by targeting IGF-1. PLoS One. 2016;11(3):e0150418.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chen Q, Zhao X, Zhang H, et al. MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. Mol Carcinog. 2015;54(11):1292–300.

    Article  CAS  PubMed  Google Scholar 

  20. Sun Y, Jia X, Hou L, Liu X. Screening of differently expressed miRNA and mRNA in prostate cancer by integrated analysis of transcription data. Urology. 2016;94(313):e1–6.

    Google Scholar 

  21. Ramalhocarvalho J, Graca I, Gomez A, et al. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. J Hematol Oncol. 2017;10:1–43.

    Article  Google Scholar 

  22. Lin J, Cao S, Wang Y, et al. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):113.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Xu S, Bai J, Zhuan Z, et al. EBV–LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma. Oncol Rep. 2018;40(1):377–84.

    CAS  PubMed  Google Scholar 

  24. Cui J, Gong C, Cao B, et al. MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA. Exp Ther Med. 2018;15(5):4349–55.

    PubMed  PubMed Central  Google Scholar 

  25. Thawan R, Thomas A, Thakur K. Tracheomediastinal fistula: rare complication of treatment with bevacizumab. Cureus. 2018;10(4):e2419.

    Google Scholar 

  26. Ham B, Fernandez MC, D'Costa Z, et al. The diverse roles of the TNF axis in cancer progression and metastasis. Trends Cancer Res. 2016;11(1):1–27.

    PubMed  PubMed Central  Google Scholar 

  27. Luo W, Tweedie D, Beedie SL, et al. Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorg Med Chem. 2018;26(8):1547–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sun H, Zhu X, Zhou Y, et al. C1q/TNF-related protein-9 ameliorates Ox-LDL-induced endothelial dysfunction via PGC-1α/AMPK-mediated antioxidant enzyme induction. Int J Mol Sci. 2017;18(6):E1097.

    Article  PubMed  Google Scholar 

  29. Tang N, Ma J, Wang KS, et al. Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression. Mol Cell Biochem. 2016;422(1–2):11–20.

    Article  CAS  PubMed  Google Scholar 

  30. Li J, Ma J, Wang KS, et al. Baicalein inhibits TNF-α-induced NF-κB activation and expression of NF-κB-regulated target gene products. Oncol Rep. 2016;36(5):2771–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr An Liu (Yueyang, China) for his generous support.

Author information

Authors and Affiliations

  1. Department of Urology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

    H. Q. Mu, Y. H. He, S. B. Wang, S. Yang, Y. J. Wang, C. J. Nan, Y. F. Bao & Y. H. Chen

  2. Clinical Laboratory, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

    Q. P. Xie

Authors
  1. H. Q. Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. H. He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. B. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. J. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. J. Nan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y. F. Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Q. P. Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Y. H. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. H. Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethics statement

This study was approved by the medical ethics committee of The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, and all the participants signed written informed consent forms.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mu, H.Q., He, Y.H., Wang, S.B. et al. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis. Clin Transl Oncol 22, 111–121 (2020). https://doi.org/10.1007/s12094-019-02217-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-019-02217-5

Keywords

Search

Navigation